01_08 Localized Pancreatic Cancer

Talking About Tumors with Ryann and Ryan - A medical oncology podcast

1. Differential for pancreatic lesion, staging of adenocarcinoma

2. Surgical considerations, post-surgical complications

3. Historical adjuvant evidence

4. An argument for neoadjuvant systemic therapy

Citations

As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com

DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.

Uptodate.com Waltham, MA: Wolters Kluwer.

Some highlighted references recommended to read related to this specific episode:

1. Fietkau et al. Rl. J Clin Oncol 2022;40(16_suppl) doi:10.1200/JCO.2022.40.16_SUPPL.4008

2. Conroy T et al. F NE JMe. 2018;379(25):2395-2406. doi:10.1056/NEJMOA1809775/

3. Tempero MA et al. J Clin Oncol. 2019;37(15_suppl) doi:10.1200/JCO.2019.37.15_SUPPL.4000

4. Neoptolemos JP et al. The Lancet. 2017;389(10073):1011-1024. doi:10.1016/S0140-6736(16)32409-6/ATTACHMENT/46BFFE67-D3AE-4DEA-822B-4A2CE28139FD/MMC1.PDF

5. Liao WC et al. Lancet Oncol. 2013;14(11):1095-1103. doi:10.1016/S1470-2045(13)70388-7

6. van Laethem JL et al. J Clin Oncol. 2010;28(29):4450-4456. doi:10.1200/JCO.2010.30.3446

7. Evans DB et al. Annals of Surgery. 2000;232(5):727. doi:10.1097/00000658-199912000-00006

8. Kaiser M, Ellenberg S. Arch Surg. 1985;120(8):899-903. doi:10.1001/ARCHSURG.1985.01390320023003

9. van Dam JL et al. Eur J Cancer. 2022;160:140-149. doi:10.1016/J.EJCA.2021.10.023

10. Versteijne E et al. J Clin Oncol. 2022;40(11):1220-1230. doi:10.1200/JCO.21.02233

11. Neoptolemos et al. NEJM. 2004;350(12):1200-1210. doi:10.1056/NEJMOA032295

12. Neoptolemos JP et al. Lancet. 2001;358(9293):1576-1585. doi:10.1016/S0140-6736(01)06651-X

Disclosures

Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.